The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Estrem Paul since 2018.
The trader's CIK number is 1722374.
At the time of the last reporting, Estrem Paul was the Chief Financial Officer of Melinta Therapeutics, Inc. /new/. (stock ticker symbol MLNT).
Also see all insider trading activities at Melinta Therapeutics, Inc. /new/.
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2018 | MLNT | 10,000 | $50,000 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2018-05-29 | MLNT | Buy | 10,000 | 5.00 | 50,000 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Estrem Paul (Chief Financial Officer of Melinta Therapeutics, Inc. /new/ at the time of this reporting) see the Securities and Exchange Commission (SEC) website.